COPD trials in China

In China 88 Also abroad 595

61 of 88 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD
Where
Chengdu
Age
18 years to 75 years
People
48
Run by
Guangdong Hengrui Pharmaceutical Co., Ltd
See details and how to joinNCT07567872
Phase 1Not yet taking people in China
Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet
Where
Guangzhou
Age
18 years to 55 years
People
40
Run by
Reistone Biopharma Company Limited
See details and how to joinNCT07696091
No phaseTaking people
Endobronchial Silicone Valve for Patients With Emphysema
Where
Beijing
Age
18 years and over
People
147
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07097896
No phaseTaking people
Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy
Where
Harbin, Hefei, Ningbo, Ninghai, Taizhou
Age
65 years and over
People
380
Run by
First Affiliated Hospital of Ningbo University
See details and how to joinNCT07030881
No phaseNot yet taking people in China
Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD
Where
Chengdu, Guangzhou, Hangzhou, Huzhou, Jiaxing, Lishui, Nanchang, Quzhou, Shanghai, Shaoxing, Taizhou, Wenzhou, Wuhan
Age
40 years and over
People
630
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07665359
Phase 3Not yet taking people in China
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD
Where
Beijing
Age
40 years to 80 years
People
387
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07658339
Phase 3Taking people
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD
Where
Beijing
Age
40 years to 80 years
People
376
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07583849
Phase 2Taking people
Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)
Where
Nanchang
Age
40 years to 80 years
People
50
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07140328
No phaseTaking people
Air Purifier Use and Respiratory Health in COPD Patients
Where
Shanghai
Age
50 years to 80 years
People
120
Run by
Fudan University
See details and how to joinNCT07505602
Phase 3Not yet taking people in China
Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPD
Where
Nanchang
Age
40 years to 80 years
People
300
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07634367
Phase 2Taking people
A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary Disease
Where
Guangzhou
Age
40 years to 80 years
People
300
Run by
Reistone Biopharma Company Limited
See details and how to joinNCT07349524
Early phase 1Taking people
Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy
Where
Yiwu
Age
40 years to 80 years
People
12
Run by
Regend Therapeutics
See details and how to joinNCT07355868
No phaseTaking people
Role of Exercise in PRISm and Subsequent Development of COPD
Where
Hong Kong
Age
18 years and over
People
90
Run by
The University of Hong Kong
See details and how to joinNCT07387432
Phase 2Not yet taking people in China
Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD
Where
Guiyang
Age
40 years to 80 years
People
300
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07425210
Phase 2Taking people
A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Where
Beijing
Age
40 years to 85 years
People
318
Run by
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT07418736
No phaseNot yet taking people in China
Ventilation-Perfusion Discrepancy Index Versus Conventional Anatomic-Physiologic Assessment for Target Lung Lobe Selection in Endobronchial Valve Placement: A Multicenter, Randomised Controlled Trial
Where
Beijing
Age
18 years and over
People
285
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07403617
No phaseTaking people
A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease
Where
Nanjing
Age
40 years to 75 years
People
16
Run by
Novlead Inc.
See details and how to joinNCT07382258
Phase 2Taking people
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD
Where
Guangzhou
Age
40 years to 80 years
People
120
Run by
Joincare Pharmaceutical Group Industry Co., Ltd
See details and how to joinNCT07351734
Phase 2Not yet taking people in China
A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD
Where
Tianjin
Age
40 years and over
People
120
Run by
Ganzhou Hemay Pharmaceutical Co., Ltd
See details and how to joinNCT07314242
Phase 2Taking people
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Where
Baotou, Beijing, Changsha, Chengdu, Chizhou, Chongqing, Hefei, Hengyang, Heze, Huizhou, Huzhou, Jiangmen, Jiaxing, Jinan, Jincheng, Jinzhou, Jiujiang, Kunming, Langfang, Lanzhou, Nanchang, Nanyang, Neimeng, Pingxiang, Qingyuan, Shanghai, Shaoyang, Shenyang, Taiyuan, Taizhou, Weifang, Xi'an, Xiangyang, Xinxiang, Xuzhou, Yangzhou, Yibin, Yichang, Yongzhou, Yueyang, Zhengzhou, Zhenjiang, Zunyi
Age
40 years to 75 years
People
360
Run by
Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT07292714
Phase 3Taking people
Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Where
Beijing, Hangzhou, Nanjing, Shenzhen
Age
40 years to 85 years
People
594
Run by
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
See details and how to joinNCT07039669
Phase 3Not yet taking people in China
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Where
Baoji, Baotou, Binzhou, Bozhou, Cangzhou, Changchun, Changsha, Changzhi, Chengdu, Chifeng, Chizhou, Chongqing, Dalian, Daqing, Foshan, Fuzhou, Guiyang, Haikou, Harbin, Hefei, Heze, Hohhot, Huizhou, Jiaozuo, Jiaxing, Jinhua, Jining, Jiujiang, Langfang, Lanzhou, Mianyang, Nanchang, Nanchong, Nanjing, Ningbo, Puyang, Qinhuangdao, Qiqihar, Shanghai, Shangqiu, Shaoxing, Shenyang, Shenzhen, Shihezi, Shijiazhuang, Suining, Taizhou, Tianjin, Weifang, Wenzhou, Wuxi, Xi'an, Xianyang, Xining, Xuzhou, Yangquan, Yangzhou, Yantai, Yichang, Yixing, Yongzhou, Zhangzhou
Age
40 years to 80 years
People
666
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07147946
No phaseTaking people
A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema
Where
Beijing, Chengdu, Linyi, Nanchang, Shanghai, Shijiazhuang, Zhejiang, Zhengzhou
Age
18 years and over
People
100
Run by
Shanghai Chest Hospital
See details and how to joinNCT06152107
No phaseTaking people
Community Exercise Treating Effect on Cardiopulmonary Disease Patients
Where
Guangzhou
Age
18 years to 85 years
People
200
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT07154355
No phaseTaking people
Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease
Where
Beijing, Changzhou, Hangzhou, Hefei, Jinhua, Lishui, Nanchang, Quzhou, Shaoxing, Suzhou, Wuxi, Xuzhou
Age
35 years to 80 years
People
210
Run by
Suzhou Hengruihongyuan Medical Technology Co. LTD
See details and how to joinNCT07068438